Ortin Global Limited (ORTINGLOBE) - Total Assets
Based on the latest financial reports, Ortin Global Limited (ORTINGLOBE) holds total assets worth Rs46.47 Million INR (≈ $502.58K USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Check total reinvestment intensity of Ortin Global Limited to assess the company's total reinvestment commitment from operating cash flow.
Ortin Global Limited - Total Assets Trend (2021–2026)
This chart illustrates how Ortin Global Limited's total assets have evolved over time, based on quarterly financial data. Check ORTINGLOBE cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.
Ortin Global Limited - Asset Composition Analysis
Current Asset Composition (March 2026)
Ortin Global Limited's total assets of Rs46.47 Million consist of 82.6% current assets and 17.4% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs0.00 | 13.0% |
| Accounts Receivable | Rs2.00 Million | 4.3% |
| Inventory | Rs0.00 | 0.0% |
| Property, Plant & Equipment | Rs0.00 | 0.0% |
| Intangible Assets | Rs0.00 | 0.0% |
| Goodwill | Rs0.00 | 0.0% |
Asset Composition Trend (2021–2026)
This chart illustrates how Ortin Global Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see ORTINGLOBE market cap.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Ortin Global Limited's current assets represent 82.6% of total assets in 2026, an increase from 28.8% in 2021.
- Cash Position: Cash and equivalents constituted 13.0% of total assets in 2026, up from 0.1% in 2021.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2021.
- Asset Diversification: The largest asset category is accounts receivable at 4.3% of total assets.
Ortin Global Limited Competitors by Total Assets
Key competitors of Ortin Global Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥14.18 Billion |
|
SIMCERE PHARMAC. GRP LTD
F:S2P
|
Germany | €14.73 Billion |
|
Curaleaf Holdings Inc.
TO:CURA
|
Canada | CA$2.88 Billion |
|
Beijing New Oriental Star Petrochemical Engineering Co Ltd
SHE:002755
|
China | CN¥4.44 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥11.13 Billion |
|
Shanghai Yizhong Pharmaceutical Co Ltd
SHG:688091
|
China | CN¥1.54 Billion |
|
Cronos Group Inc
TO:CRON
|
Canada | CA$1.18 Billion |
|
Renhe Pharmacy Co Ltd
SHE:000650
|
China | CN¥7.93 Billion |
Ortin Global Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.60 | 2.15 | 0.67 |
| Quick Ratio | 1.60 | 2.14 | 0.22 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | Rs14.32 Million | Rs17.89 Million | Rs-18.33 Million |
Ortin Global Limited - Advanced Valuation Insights
This section examines the relationship between Ortin Global Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 11.27 |
| Latest Market Cap to Assets Ratio | 0.03 |
| Asset Growth Rate (YoY) | 22.9% |
| Total Assets | Rs46.47 Million |
| Market Capitalization | $1.50 Million USD |
Valuation Analysis
Below Book Valuation: The market values Ortin Global Limited's assets below their book value (0.03x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: Ortin Global Limited's assets grew by 22.9% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for Ortin Global Limited (2021–2026)
The table below shows the annual total assets of Ortin Global Limited from 2021 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-03-31 | Rs46.47 Million ≈ $502.58K |
+22.91% |
| 2025-03-31 | Rs37.81 Million ≈ $408.89K |
-43.27% |
| 2024-03-31 | Rs66.64 Million ≈ $720.72K |
-68.56% |
| 2023-03-31 | Rs211.97 Million ≈ $2.29 Million |
+2.38% |
| 2022-03-31 | Rs207.05 Million ≈ $2.24 Million |
-2.64% |
| 2021-03-31 | Rs212.66 Million ≈ $2.30 Million |
-- |
About Ortin Global Limited
Ortin Global Limited engages in the manufacture and trading of pharmaceuticals, drugs, and intermediates in India. The company offers various pharmaceutical formulations of tablets, capsules, syrups, and dry powders; formulations, such as anti-diabetics, anti-allergics, anti-anginal and cardiovascular, sedatives and tranquilisers, anti-helmenthetics, analgesics and antipyretics, anti-biotics-quin… Read more